Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Cytokinetics Inc. (CYTK)

Pharmaceutical Preparations

https://www.cytokinetics.com

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

350 OYSTER POINT BOULEVARD, .
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/29/2004

Market Cap

6,627,787,800

Shares Outstanding

98,050,000

Weighted SO

98,053,647

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

DICE --.--%

DICE --.--%

EWTX --.--%

EWTX --.--%

KRTX --.--%

KRTX --.--%

DYN --.--%

STOK --.--%

STOK --.--%

Beta

0.7530

Last Div

0.0000

Range

25.98-110.25

Chg

-0.7300

Avg Vol

2014701

Mkt Cap

6627787800

Exch

NASDAQ

Country

US

Phone

650 624 3000

DCF Diff

66.0934

DCF

-9.5234

Div Yield

0.0000

P/S

2114.8015

EV Multiple

-14.8049

P/FV

56.6881

Div Yield %

0.0000

P/E

-11.2850

PEG

-0.6598

Payout

0.0000

Current Ratio

10.3896

Quick Ratio

10.3896

Cash Ratio

1.8537

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

36.9274

CCC

-36.9274

Gross Margin

-28.8673

Op Margin

-161.4837

Pretax Margin

-173.9882

Net Margin

-173.9882

Eff Tax Rate

-0.0202

ROA

-0.3578

ROE

1.9601

ROCE

-0.3561

NI/EBT

1.0000

EBT/EBIT

1.0774

EBIT/Rev

-161.4837

Debt Ratio

0.4420

D/E

6.2041

LT Debt/Cap

0.8556

Total Debt/Cap

0.8612

Int Coverage

-14.1965

CF/Debt

-0.5926

Equity Multi

14.0377

Rec Turnover

0.0000

Pay Turnover

9.8843

Inv Turnover

0.0000

FA Turnover

0.0219

Asset Turnover

0.0021

OCF/Share

-3.6531

FCF/Share

-3.6573

Cash/Share

9.6773

OCF/Sales

-127.3331

FCF/OCF

1.0011

CF Coverage

-0.5926

ST Coverage

-13.2901

CapEx Coverage

-871.3144

Div&CapEx Cov

-871.3144

P/BV

56.6881

P/B

56.6881

P/S

2114.8015

P/E

-11.2850

P/FCF

-16.5894

P/OCF

-15.4199

P/CF

-15.4199

PEG

-0.6598

P/S

2114.8015

EV Multiple

-14.8049

P/FV

56.6881

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 16, 14:00 Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024 GlobeNewswire Inc. Nov 16, 14:00 Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024 GlobeNewswire Inc. May 23, 03:30 Cytokinetics Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. Jan 18, 13:00 Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024 Benzinga Jan 12, 14:38 Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst MarketWatch Jan 09, 05:19 GSK to buy asthma drug developer for up to $1.4 billion in pipeline push The Motley Fool Jan 03, 06:45 2 Biotechs That Could Get Bought Out in 2024 Benzinga Dec 28, 12:19 Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch Benzinga Dec 28, 12:19 Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch Benzinga Dec 28, 08:35 Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday MarketWatch Dec 27, 16:06 Dow Jones posts record close as stocks end mostly higher MarketWatch Dec 27, 16:06 Dow Jones posts record close as stocks end mostly higher MarketWatch Dec 27, 14:03 Dow Jones on track for record close as stocks nudge higher MarketWatch Dec 27, 14:03 Dow Jones on track for record close as stocks nudge higher MarketWatch Dec 27, 11:59 Dow Jones on track for record close as stocks nudge mostly higher MarketWatch Dec 27, 11:14 U.S. stocks remain flat with S&P 500 just shy of record high as interest rate optimism holds sway MarketWatch Dec 27, 10:14 Cytokinetics' stock rockets to 19-year high after positive data on heart-disease treatment MarketWatch Dec 27, 09:35 U.S. stocks open flat with S&P 500 just shy of record high as interest rate optimism holds sway GlobeNewswire Inc. Dec 27, 07:30 Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy GlobeNewswire Inc. Dec 07, 07:30 Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND

Revenue Product Segmentation